辦公室：附屬華南醫(yī)院科教樓1302 導(dǎo)師類別：碩導(dǎo)
郵箱：liyuqing@email.szu.edu.cn 辦公室電話：0755-21583934
個人簡介
李宇清，研究員，博士生導(dǎo)師。深圳大學(xué)附屬華南醫(yī)院實驗研究部負(fù)責(zé)人，生物治療中心副主任，干細(xì)胞與轉(zhuǎn)化研究所所長。入選“中國博士后創(chuàng)新人才支持計劃”（博新計劃）。發(fā)表SCI論文30余篇，作為主要作者在Cancer Research和PNAS等雜志發(fā)表論文10余篇，獲得國家級和省部級項目5項。
主要研究方向
生物多組學(xué)大數(shù)據(jù)分析和提取
代表性成果等
1) Liang M#, Wang Y#, Liu L, Deng D, Yan Z, Feng L, Kong C, Li C, Li Y*, Li G*. Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy. Journal of Experimental & Clinical Cancer Research. 2024 Aug 12;43(1):223.
2) Zhang L#, Li Y#, Zhou L#, Zhou H, Ye L, Ou T, Hong H, Zheng S, Zhou Z, Wu K, Yan Z, Thiery JP, Cui J, Wu S. The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response. Cancer Research. 2023 Jun 2;83(11):1834-1850.
3) Zhou H#, Zhang L#, Luo W, Hong H, Tang D, Zhou D, Zhou L*, Li Y*. AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma. Frontiers in Pharmacology. 2022 Oct 31;13:1050774.
4) Li C#, Li Y#, Li G*, Wu S*. Functional Nanoparticles for Enhanced Cancer Therapy. Pharmaceutics. 2022 Aug 12;14(8):1682.
5) Wang S#, Li Y#, Zhong L#, Wu K, Zhang R, Kang T, Wu S*, Wu Y*. Efficient gene editing through an intronic selection marker in cells. Cellular and Molecular Life Science. 2022 Jan 31;79(2):111.
6) Chen Q#, Chen J#, Li Y#, Liu D, Zeng Y, Tian Z, Yunus A, Yang Y, Lu J, Song X*, Yuan Y*, Kaposi's Sarcoma Herpesvirus is Associated with Osteosarcoma in Xinjiang Populations, the Proceedings of the National Academy of Sciences (PNAS), 2021 Mar 9;118(10):e2016653118.
7) Li Y#, Zhong C#, Liu D, Yu W, Chen W, Wang Y, Shi S, Yuan Y*, Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition, Cancer Research, 2018 Jan 1;78(1):230-245.
8) Long X#, Li Y#, Yang M, Huang L, Gong W, Kuang E*, BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-infected Cells by Downregulating Tumor Necrosis Factor Alpha, Journal of Virology, 2016 Aug 12; 90(17): 7880-7893.
9) Li Y, Long X, Huang L, Yang M, Yuan Y, Wang Y, Delecluse HJ, Kuang E*, Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors is Essential for Optimal Lytic Viral Replication, Journal of Virology, 2015 Nov 4; 90(2): 887-903.
照片
